Trial NCT01705483

View at ClinicalTrials.gov 
Org. Study IDs: 9853-CL-0101

Last trial update was posted on 2019-05-30

MeSH Interventions

Docetaxel Paclitaxel

MeSH Conditions

Neoplasms

Other Conditions

Non-hematologic Malignancies Pharmacokinetics of ASP9853

Stopping Reasons

Based on the results of the Phase 1 data, the company decided not to pursue the development of this drug at this time.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID